Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07275554

Analysis of Methylomic Features and Prognostic Risk Prediction in Patients With Hepatitis B-related Acute-on-chronic Liver Failure

Status
Recruiting
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Qilu Hospital of Shandong University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study aims to investigate the methylomic features of patients with hepatitis B-related acute-on-chronic liver failure and establish and validate a prognostic risk prediction classification model. The findings are of significant importance for guiding clinical practice and improving patient prognosis. Additionally, a methylomics-based classifier model for liver failure will be developed for disease prognosis analysis and clinical assessment, with the potential to enhance the diagnostic efficiency of liver failure.

Conditions

Timeline

Start date
2024-12-31
Primary completion
2026-12-31
Completion
2026-12-31
First posted
2025-12-10
Last updated
2025-12-10

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT07275554. Inclusion in this directory is not an endorsement.

Analysis of Methylomic Features and Prognostic Risk Prediction in Patients With Hepatitis B-related Acute-on-chronic Liv (NCT07275554) · Clinical Trials Directory